Law Offices of Howard G. Smith Announces Investigation of Inhibitex, Inc.
10 1월 2012 - 9:03AM
Business Wire
Law Offices of Howard G. Smith announces that it is
investigating potential claims against the Board of Directors of
Inhibitex, Inc. (“Inhibitex” or the “Company”) (NASDAQ:INHX)
related to the proposed acquisition of the Company by Bristol-Myers
Squibb Co. The transaction is valued at approximately $2.5 billion
or $26.00 per share.
The investigation concerns whether the Board of Directors of
Inhibitex breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter
into the proposed transaction, and whether the Company has
disclosed all material information to shareholders about the
transaction. The Company has seen substantial recent growth. Its
share price has skyrocketed from $2.16 on March 2, 2011 to $15.51
on December 2, 2011.
If you are a shareholder of Inhibitex, if you have information
or would like to learn more about these claims, or if you wish to
discuss these matters or have any questions concerning this
announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at
(888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or
visit our website at http://www.howardsmithlaw.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Inhibitex, Inc. (MM) (NASDAQ:INHX)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
